MedTrace Logo

Secondary Central Nervous System Lymphoma Registry - Charité

NCT05114330 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2023-11-27

No results posted yet for this study

Summary

The objective of the observation is to collect and document data on treatment strategies for secondary central nervous system lymphoma (SCNSL) in routine clinical practice, whether obtained in the context of clinical trials or outside of trials. In particular, the following questions will be specified:

* What therapeutic approaches are being pursued?
* What is the clinical outcome of the various treatment options?
* What is the frequency of serious adverse events with each therapeutic approach?

Conditions

Sponsors & Collaborators

  • Charite University, Berlin, Germany

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-08
Primary Completion
2024-06-08
Completion
2026-06-08

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05114330 on ClinicalTrials.gov